Quick Answer
TREACE MEDICAL CONCEPTS, INC. reported Cash and Equivalents of $10.71 million for fiscal year 2025.
TREACE MEDICAL CONCEPTS, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $10.71M | -5.7% |
| 2024 | $11.35M | -12.6% |
| 2023 | $12.98M | -33.3% |
| 2022 | $19.47M | -81.6% |
| 2021 | $105.83M | +485.4% |
| 2020 | $18.08M | +48.9% |
| 2019 | $12.14M | +845.4% |
| 2018 | $1.28M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $7.69M | -36.5% | -4.5% |
| June 30, 2025 | $8.05M | -55.7% | -39.8% |
| March 31, 2025 | $13.37M | +43.3% | +17.8% |
| December 31, 2024 | $11.35M | -12.6% | -6.3% |
| September 30, 2024 | $12.11M | +66.4% | -33.4% |
| June 30, 2024 | $18.18M | +51.1% | +94.8% |
| March 31, 2024 | $9.33M | -68.5% | -28.1% |
| December 31, 2023 | $12.98M | -33.3% | +78.4% |
- TREACE MEDICAL CONCEPTS, INC. showed a decrease of -5.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2018–2025 period, TREACE MEDICAL CONCEPTS, INC.’s cash and equivalents has grown by 734.0% (from $1.28 million to $10.71 million).
- The most recent figure is from TREACE MEDICAL CONCEPTS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: